Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of
triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain.
The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic
block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic
block").
Phase:
Phase 3
Details
Lead Sponsor:
The Cleveland Clinic
Collaborators:
American Society for Gastrointestinal Endoscopy TAP Pharmaceutical Products Inc.